The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results-Reference-Cited by-同舟云学术

The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results

Published:2009-03 Issue:2 Volume:10 Page:97-104
ISSN:1399-543X
Container-title:Pediatric Diabetes
language:en
Short-container-title:

Author:

Mahon Jeffrey L,Sosenko Jay M,Rafkin-Mervis Lisa,Krause-Steinrauf Heidi,Lachin John M,Thompson Clinton,Bingley Polly J,Bonifacio Ezio,Palmer Jerry P,Eisenbarth George S,Wolfsdorf Joseph,Skyler Jay S, ,

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Pediatrics, Perinatology and Child Health,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1399-5448.2008.00464.x/fullpdf

Reference33 articles.

1. Type 1 diabetes: new perspectives on disease pathogenesis and treatment;Atkinson;Lancet,2001

2. Guidelines for intervention trials in subjects with newly diagnosed type 1 diabetes;Greeenbaum;Diabetes,2003

3. Effects of insulin in relatives of patients with type 1 diabetes mellitus;The Diabetes Prevention Trial - Type 1 Study Group;N Engl J Med,2002

4. ENDIT: a randomized controlled trial of intervention before onset of type 1diabetes;European Nicotinamide Diabetes Intervention Trial (ENDIT) Group;Lancet,2004

5. Effects of oral insulin in relatives of patients with type 1 diabetes;The Diabetes Prevention Trial - Type 1 Study Group;Diabetes Care,2005

Cited by 158 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic Associations With C-peptide Levels Before Type 1 Diabetes Diagnosis in At-risk Relatives;The Journal of Clinical Endocrinology & Metabolism;2024-05-20

2. Lower Prevalence of Diabetic Ketoacidosis at Diagnosis in Research Participants Monitored for Hyperglycemia;The Journal of Clinical Endocrinology & Metabolism;2024-03-12

3. Genetic and Epigenetic Aspects of Type 1 Diabetes Mellitus: Modern View on the Problem;Biomedicines;2024-02-08

4. Teplizumab: promises and challenges of a recently approved monoclonal antibody for the prevention of type 1 diabetes or preservation of residual beta cell function;Expert Review of Clinical Immunology;2023-11-12

5. HOMA-IR and the Matsuda Index as predictors of progression to type 1 diabetes in autoantibody-positive relatives;Diabetologia;2023-11-02